- ►inti.com.bo [PDF] P Angulo - New England Journal of Medicine, 2002 - content.nejm.org Nonalcoholic fatty liver disease is an increasingly recognized condition that
may progress to end-stage liver disease. The pathological picture resembles that
of alcohol-induced liver injury, but it occurs in patients who do not abuse ... Cited by 1463 - Related articles - All 17 versions
BA Neuschwander-Tetri, SH Caldwell - Hepatology, 2003 - ualberta.ca Fatty liver disease that develops in the absence of alcohol abuse is recognized
increasingly as a major health burden. This report summarizes the presentations
and discussions at a Single Topic Conference held September 20-22, 2002, ... Cited by 821 - Related articles - View as HTML - BL Direct - All 9 versions
G Marchesini, E Bugianesi, G Forlani, F … - Hepatology, 2003 - interscience.wiley.com Nonalcoholic fatty liver disease (NAFLD) has been associated with the
insulin-resistance syndrome, at present defined as the metabolic syndrome, whose
limits were recently set. We assessed the prevalence of the metabolic ... Cited by 741 - Related articles - BL Direct - All 3 versions
EM Brunt - Seminars in liver disease, 2001 - thieme-connect.com Nonalcoholic steatohepatitis (NASH) is a significant form of chronic liver
disease in adults and children. The natural history of NASH ranges from indolent
to end-stage liver disease. Current studies are focusing on identification ... Cited by 630 - Related articles - BL Direct - All 10 versions
JM Clark, FL Brancati, AM Diehl - Gastroenterology, 2002 - Elsevier GASTROENTEROLOGY 2002;122:1649-1657Nonalcoholic Fatty Liver DiseaseJEANNE M.
CLARK, FREDERICK L. BRANCATI, and ANNA MAE DIEHLDepartments of Medicine and
Epldemiology, The Johns Hopkins University, Baltimore, ... Cited by 537 - Related articles - BL Direct - All 17 versions
JD Browning, LS Szczepaniak, R Dobbins, P … - Hepatology, 2004 - interscience.wiley.com Despite the increasing prevalence of nonalcoholic fatty liver disease (NAFLD),
its pathogenesis and clinical significance remain poorly defined. In this study,
we examined and compared the distribution of hepatic triglyceride content ... Cited by 519 - Related articles - All 3 versions
- ►nih.gov JD Browning, JD Horton - Journal of Clinical Investigation, 2004 - Am Soc Clin Investig Obesity and its associated comorbidities are among the most prevalent and
challenging conditions confronting the medical profession in the 21st century. A
major metabolic consequence of obesity is insulin resistance, which is ... Cited by 474 - Related articles - BL Direct - All 15 versions
- ►annals.org [PDF] D Prati, E Taioli, A Zanella, ED Torre, S … - Annals of internal medicine, 2002 - Am Coll Physicians Updated Definitions of Healthy Ranges for Serum Alanine ... Daniele Prati, MD;
Emanuela Taioli, MD, PhD; Alberto Zanella, MD; Emanuela Della Torre, DSc; Sonia
Butelli, DSc; Emanuela Del Vecchio, DSc; Luciana Vianello, MD; Francesco ... Cited by 418 - Related articles - BL Direct - All 4 versions
- ►ucsf.edu [PDF] Y Falck-Ytter, ZM Younossi, G Marchesini, … - Seminars in Liver Disease, 2001 - thieme-connect.com Nonalcoholic steatohepatitis, along with other forms of nonalcoholic fatty liver
disease, is a chronic liver disease that is attracting increasing significance.
It is a clinicopathologic syndrome that was originally described in obese, ... Cited by 397 - Related articles - BL Direct - All 6 versions
GC Farrell, CZ Larter - Hepatology, 2006 - gidiv.ucsf.edu Nonalcoholic steatohepatitis (NASH), the lynchpin between steatosis and
cirrhosis in the spectrum of nonalcoholic fatty liver disorders (NAFLD), was
barely recognized in 1981. NAFLD is now present in 17% to 33% of Americans, ... Cited by 386 - Related articles - View as HTML - BL Direct - All 4 versions
